Together with around 400 guests, the University of Augsburg celebrated a new milestone in the university’s history: the opening of the new teaching building for the Faculty of Medicine and its growing number of young medical students. This marked the opening of Augsburg’s new medical campus. Bavarian State Minister for Science and the Arts, Markus Blume, and the founding dean of the Faculty of Medicine (2017-2019), Prof Guido Adler, gave keynote addresses.

With the help of funding from the German Research Foundation (DFG), a new Centre for Electron Microscopy is being established at the Institute of Physics. The aim is to create an organisational infrastructure that enables effective use of cutting-edge equipment by researchers at other institutes within the university as well as by external research institutes.

Liquid biopsy is a very precise method by which to diagnose cancer, which is much less invasive than conventional tissue sampling. The course of cancer treatment and its success can be comprehensively monitored using this method and tumours treated more accurately. A long-term clinical study at the Faculty of Medicine at the University of Augsburg is now focusing on the question of how liquid biopsy can be used in everyday clinical practice. Initial results have been published in the Journal of Laboratory Medicine.

A heat action plan for the University Hospital Augsburg is being developed by researchers at the Chair for Regional Climate Change and Health at the Faculty of Medicine in collaboration with the Centre for Occupational Medicine at the University Hospital Augsburg. Over the next two years, researchers in the recently started “ProTect” project will analyse heat stress, develop measures to address it, and then evaluate the measures in order to help the hospital cope with heatwaves.

Researchers at Augsburg University Medicine have discovered a possible early detection method of the rare Borna virus. Their results have been published in the highly renowned medical journal “The Lancet.” In humans the virus triggers inflammation in the brain which is almost always deadly and is transmitted to humans by shrews. 

On March 11, 2024, the inauguration of the expanded safety laboratory in Augsburg marked a milestone within the EU-funded "PerForM-REACT" project, aimed at enhancing pandemic preparedness. Equipped with high-tech infrastructure, this facility enables advanced research capabilities. A collaborative effort between Helmholtz Munich and the University Hospital Augsburg, the project not only boosters the efficacy of pandemic prevention but also fosters interdisciplinary cooperation in health research.

Prof. Dr Dorothee Mielke to assume overall responsibility for the Clinic of Neurosurgery at Augsburg’s University Hospital

Scientists from Augsburg's Faculty of Medicine have had a new article published in the internationally renowned journal Molecular Cancer. The authors, Dr Tatjana Sauerer, Giuliano Filippini Velázquez, and Prof. Dr Christoph Schmid, describe the mechanisms by which leukaemia cells evade immune system control, causing relapses even after allogeneic stem cell transplantation. They also present new individualised therapy options.

Attention deficit hyperactivity disorder (ADHD) is a neural developmental disorder that occurs among children and young people, which in two thirds of cases carries over into adulthood. It is estimated to affect around 5 percent of children and young people and about 2.5 percent of adults worldwide. A recently published study by the Chair of Epidemiology at the University of Augsburg in the renowned journal BMJ Mental Health shows that ADHD often occurs in association with severe depression, post-traumatic stress disorder, the eating disorder Anorexia nervosa, as well as attempted suicide.

Together with Munich, Augsburg is home to a new site of the German Centre for Mental Health. The aim of the new centre is interdisciplinary research into the development and progress of mental illnesses across the lifespan. The Augsburg site of the new centre will focus on researching treatments for depression. Funded by the Federal Ministry of Education and Research (BMBF), the new centre (DZPG) consists of five research sites in addition to Munich/Augsburg.

Scientists at the University of Augsburg and Helmholtz Munich have made an important breakthrough in better understanding early processes in the development of type 2 diabetes by identifying a previously unknown transmission of messenger substances from adipose tissue to the pancreas.

University medicine at Augsburg belongs to a network of four university hospitals, including Würzburg, Erlangen, and Regensburg (WERA), which have joined forces for the first time to form a new Bavarian site for the National Centre for Tumor Diseases (NCT) as part of the German Cancer Research Centre (DZKF).